Healthcare & Medical Devices Global On demand · 24-48h

Global Biorepository Storage Service Market Strategic Research Report

Global Biorepository Storage Service Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Biorepository Storage Service Market
$7022025
9.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Ambient Storage Service, Refrigerated Storage Service, Frozen Storage Service, Ultra-low Temperature Storage Service, Liquid Nitrogen Storage Service

By Application: Pharmaceutical, Research, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, IQVIA, Labcorp, Eurofins, Merck, Quest Diagnostics, ICON, Charles River Laboratories, EPL Archives (VWR), Precision for Medicine, Azenta, Cryoport, Alcami, Kryosphere, BioArkive, Tescor, Precision Stability Storage, Birka BioStorag, Medpace, HKSTP, WuXi AppTec, Shanghai Outdo Biotech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 145 pages
Market size 2025
$702
Million USD
Forecast CAGR
9.8%
2025-2032
Forecast 2032
$1350.7
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Biorepository Storage Service market size is predicted to grow from US$ 702 million in 2025 to US$ 1,339 million in 2032; it is expected to grow at a CAGR of 9.8% from 2026 to 2032.

Biorepository Storage Service refers to professional services that provide storage, temperature-controlled preservation, inventory management, and quality assurance for biospecimens used in life science research, clinical trials, medical testing, biopharmaceutical development, and biobank operations. The service typically covers blood, serum, plasma, urine, saliva, tissue, cells, nucleic acids, microbial samples, and other clinical or research specimens. By using different storage conditions such as ambient, refrigerated, frozen, ultra-low temperature, or liquid nitrogen storage, together with processes including sample receipt, labeling, aliquoting, accessioning, retrieval, logistics coordination, environmental monitoring, information tracking, and compliance documentation, the service helps ensure sample stability, traceability, and usability throughout the storage period.

Biorepository Storage Service is a fundamental enabling service in life science research, clinical trials, precision medicine, and biopharmaceutical development. Market demand is mainly driven by the growing need of pharmaceutical companies, CROs, medical institutions, research institutes, diagnostic companies, and biobanks for long-term sample stability, standardized management, and compliant traceability. With the development of multicenter clinical studies, translational medicine, genetic testing, companion diagnostics, and real-world research, biospecimens are becoming more diverse, larger in volume, and more closely linked to clinical and research data. This raises higher requirements for temperature control, sample integrity, information management, quality systems, and cross-regional service capabilities. Overall, the market is evolving from basic frozen storage toward integrated biospecimen management services covering sample receipt, processing, aliquoting, cryopreservation, inventory management, quality control, data management, and regulatory support. Professional service providers with standardized operations and long-term service experience are better positioned to gain recognition from pharmaceutical and clinical research customers.

This report presents a comprehensive overview of the global Biorepository Storage Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Ambient Storage Service
  • Refrigerated Storage Service
  • Frozen Storage Service
  • Ultra-low Temperature Storage Service
  • Liquid Nitrogen Storage Service

Segment by Sample Type

  • Blood and Blood Component Storage Service
  • Tissue Specimen Storage Service
  • Body Fluid Specimen Storage Service
  • Cell Sample Storage Service
  • Others

Segment by Application

  • Pharmaceutical
  • Research
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Biorepository Storage Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical, Research, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Biorepository Storage Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$702
2025
Forecast
$1350.7
2032
CAGR
9.8%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificIQVIALabcorpEurofinsMerckQuest DiagnosticsICONCharles River Laboratories
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Ambient Storage ServiceRefrigerated Storage ServiceFrozen Storage ServiceUltra-low Temperature Storage ServiceLiquid Nitrogen Storage Service
By Application
PharmaceuticalResearchOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Ambient Storage Service
  • 3.1.3 Refrigerated Storage Service
  • 3.1.4 Frozen Storage Service
  • 3.1.5 Ultra-low Temperature Storage Service
  • 3.1.6 Liquid Nitrogen Storage Service
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical
  • 4.1.3 Research
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 IQVIA
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Labcorp
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Eurofins
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Merck
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Quest Diagnostics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ICON
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Charles River Laboratories
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 EPL Archives (VWR)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Precision for Medicine
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Azenta
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Cryoport
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Alcami
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Kryosphere
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 BioArkive
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Tescor
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Precision Stability Storage
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Birka BioStorag
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Medpace
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 HKSTP
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 WuXi AppTec
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Shanghai Outdo Biotech
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Biorepository Storage Service market?
The global Biorepository Storage Service market is estimated at US$ 702 million in 2025 (base year) and is projected to reach US$ 1.34 billion by 2032.
How fast is the Biorepository Storage Service market expected to grow?
The market is expected to grow at a CAGR of 9.8% from 2026 to 2032, expanding from US$ 702 million in 2025 to US$ 1.34 billion in 2032, roughly 1.9 times its base-year value.
What does the Biorepository Storage Service market cover?
Biorepository Storage Service refers to professional services that provide storage, temperature-controlled preservation, inventory management, and quality assurance for biospecimens used in life science research, clinical trials, medical testing, biopharmaceutical development, and biobank operations. The service typically covers blood, serum, plasma, urine, saliva, tissue, cells, nucleic acids, microbial samples, and other clinical or research specimens.
What are the main segments of the Biorepository Storage Service market by type?
By type, the market is segmented into Ambient Storage Service, Refrigerated Storage Service, Frozen Storage Service, Ultra-low Temperature Storage Service and Liquid Nitrogen Storage Service.
Which applications drive demand in the Biorepository Storage Service market?
Key applications covered include Pharmaceutical, Research and Others.
Who are the key players in the Biorepository Storage Service market?
Key players profiled include Thermo Fisher Scientific, IQVIA, Labcorp, Eurofins, Merck, Quest Diagnostics, ICON and Charles River Laboratories, among 22 companies covered in total.
Which regions and countries are covered for Biorepository Storage Service?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Biorepository Storage Service market?
Market demand is mainly driven by the growing need of pharmaceutical companies, CROs, medical institutions, research institutes, diagnostic companies, and biobanks for long-term sample stability, standardized management, and compliant traceability.
Who should buy the Biorepository Storage Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical, Research and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Biorepository Storage Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.